Aller au contenu

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of NUT carcinoma and other cancers: results of a phase I/II open-label, dose escalation study

Nom du journal : Int J Cancer

Année : 2021

Volume : 150

Page de départ : 993

Page de fin : 1006

Auteurs: O'Dwyer PJ, Dhar A, Kremer BE, Horner T, Wu Y, McCabe MT, Foley SW, Datta A, Khaled A, Wyce A, Ferron-Brady G, Keedy VL, French CA, Azad AA, Hann CL, Trigo J, Braña Garcia I, de Bono JS, Piha-Paul SA, Shapiro GI, Hemming ML, Plummer R, Moreno V, Cousin S, Le Tourneau C, Im SA, Cassier PA, Sablin MP, Italiano A, Blay JY,